Showing 281-290 of 2321 results for "".
Inclusive Research for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inclusive-research-for-multiple-sclerosis/31755/Inclusive research improves quality of scientific data, facilitates discovery of safety and efficacy, and assists in identifying population-specific differences.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Bruton Tyrosine Kinase Inhibition in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/bruton-tyrosine-kinase-inhibition-in-multiple-sclerosis/31872/The missing link for treatment optimization?Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.Managing Symptoms of Anxiety, Panic, Depression, Apathy, and Pseudobulbar Effect in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/managing-symptoms-of-anxiety-panic-depression-apathy-and-pseudobulbar-effect-in-individuals-with-parkinson-disease/37655/Neuropsychiatric symptoms associated with Parkinson disease, including anxiety, panic, depression, apathy, and pseudobulbar affect, require careful assessment as well as consideration of various treatment options to improve quality of life in this population.Prodromal and Early Parkinson's Disease Diagnosis
https://practicalneurology.com/diseases-diagnoses/movement-disorders/prodromal-and-early-parkinsons-disease-diagnosis/30241/Earlier diagnosis may lead to earlier and more effective treatments.Uncertainties About Cardiac Monitoring After Cryptogenic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/uncertainties-about-cardiac-monitoring-after-cryptogenic-stroke/30442/Despite a bevy of options to manage atrial fibrillation, many questions remain unanswered regarding the utility of monitoring and anticoagulation.Updates in Diagnostic Testing in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/A review of diagnostic tests for Parkinson disease, including DAT-SPECT, α-synuclein skin biopsy and CSF studies, and genetic testing, offering guidance on their appropriate use and interpretation.Etiology and Treatment of Urogenital Dysfunction in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/etiology-and-treatment-of-urogenital-dysfunction-in-individuals-with-parkinson-disease/37653/Urogenital dysfunction is a common nonmotor symptom observed in people with Parkinson disease which can negatively impact quality of life, necessitating careful investigation and prompt treatment.MOC and Physician Burnout
https://practicalneurology.com/columns/practice-management/moc-and-physician-burnout/30405/Treating the Cause, Not the Symptoms